Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-20-104523
Date:2020-09-09
Issuer: PACIRA BIOSCIENCES, INC. (PCRX)
Original Submission Date:

Reporting Person:

WICKI ANDREAS
GOVERNORS SQUARE, SUITE 4-212-2
23 LIME TREE BAY AVE, WEST BAY GRAND CAYMAN, E9 00000

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-09-09 S 2,216 d $62.02 692,970 indirect f2
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $62.00 to $62.05, inclusive. upon request, the reporting person undertakes to provide the issuer, any security holder of the issuer, or the securities and exchange commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote one (1) of this form 4.
f2 these shares are held by hbm healthcare investments (cayman) ltd. ("hbm"), of which mr. wicki is a member of the board of directors. the board of directors of hbm acts by majority vote, and mr. wicki does not have sole voting or investment power with respect to the shares. mr. wicki disclaims beneficial ownership of such shares for the purposes of rule 16a-1(a) under the securities exchange act of 1934, as amended (the "exchange act"), except to the extent of his pecuniary interest therein, if any. this report on form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of section 16 of the exchange act, or for any other purpose.
WhaleWisdom Logo

Elevate your investments